A Study of PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis
- First Posted Date
- 2017-11-08
- Last Posted Date
- 2020-08-20
- Lead Sponsor
- Prothena Biosciences Limited
- Target Recruit Count
- 21
- Registration Number
- NCT03336580
- Locations
- ๐บ๐ธ
Tufts Medical Center, Boston, Massachusetts, United States
๐บ๐ธPenn Presbyterian Medical Center, Philadelphia, Pennsylvania, United States
๐ต๐นCentro Hospitalar do Porto, Porto, Portugal
Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis
- First Posted Date
- 2015-12-15
- Last Posted Date
- 2018-05-04
- Lead Sponsor
- Prothena Biosciences Limited
- Target Recruit Count
- 48
- Registration Number
- NCT02630901
- Locations
- ๐บ๐ธ
UPMC Department of Dermatology, Pittsburgh, Pennsylvania, United States
๐บ๐ธDermatology Treatment and Research Center, PA, Dallas, Texas, United States
๐บ๐ธRenstar Medical Research, Ocala, Florida, United States
Single Ascending Dose Study of PRX003 in Healthy Subjects
- First Posted Date
- 2015-06-01
- Last Posted Date
- 2016-03-16
- Lead Sponsor
- Prothena Biosciences Limited
- Target Recruit Count
- 40
- Registration Number
- NCT02458677
- Locations
- ๐บ๐ธ
Worldwide Clinical Trials Early Phase Services, San Antonio, Texas, United States
Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's Disease
- First Posted Date
- 2014-06-06
- Last Posted Date
- 2016-10-21
- Lead Sponsor
- Prothena Biosciences Limited
- Target Recruit Count
- 64
- Registration Number
- NCT02157714
- Locations
- ๐บ๐ธ
Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States
๐บ๐ธCollaborative Neuroscience Network, LLC, Long Beach, California, United States
๐บ๐ธParkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, Florida, United States
Single Ascending Dose Study of PRX002 in Healthy Subjects
- First Posted Date
- 2014-03-24
- Last Posted Date
- 2015-02-10
- Lead Sponsor
- Prothena Biosciences Limited
- Target Recruit Count
- 40
- Registration Number
- NCT02095171
ยฉ Copyright 2025. All Rights Reserved by MedPath